Nice little retest of 1.1 there and bounced straight back to 1.3 with support building at 1.2. This is looking primed for an arvo run.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling